≡ Risteys
R13

Documentation Changelog GitHub Contact & Feedback

Malignant neoplasm of bone and articular cartilage

DOID Endpoint Browser PheWeb

C3_BONE_CARTILAGE

bone neoplasm: A benign, intermediate, or malignant neoplasm involving the bone or articular cartilage.

Suggest a new description

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps

FinnGen

Phenotype data

519972

1. Apply sex-specific rule

None

519972

2. Check conditions

None

519972

3. Check pre-conditions, main-only, mode, registry filters

None

0 out of 7 registries used, show all original rules.

0

4. Check minimum number of events

None

0

5. Include endpoints

349

6. Filter based on genotype QC (FinnGen only)

338

Control definitions (FinnGen only)

Control exclude
C3_CANCER, C3_CANCER_WIDE

Extra metadata

Level in the ICD hierarchy
2
First used in FinnGen datafreeze
DF4

Similar endpoints

↥

Case counts by codes

↥

FinnGen case counts by registry codes:

No data for upset plot.

No data for upset table.

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 338 152 186
Unadjusted period prevalence (%) 0.07 0.05 0.09
Median age at first event (years) 53.10 50.43 55.27

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
349
Matched controls
3490
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
H02AB02
ATC
dexamethasone; systemic
94.3
190.6
101
15
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
77.7
168.6
92
16
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
308.9
140.3
134
7
130
Kela drug reimbursment
Malignant tumour
+∞
125.8
113
*
A04AA01
ATC
ondansetron; systemic, rectal
29.6
119.3
84
37
JN4BD
NOMESCO Finland
Extensive body CT
17.1
105.4
98
78
N02AA05
ATC
oxycodone; systemic
10.3
99.7
150
238
JN4AD
NOMESCO Finland
Body CT examination
15.0
94.9
95
85
XX3DW
NOMESCO Finland
Time consuming IT work
14.5
80.5
80
70
NK6CT
NOMESCO Finland
Bone biopsy with CT guidance
+∞
78.1
72
*
L03AA02
ATC
filgrastim; parenteral
453.6
75.9
73
*
A03FA01
ATC
metoclopramide; systemic, rectal
8.4
74.4
124
215
XW000
NOMESCO Finland
Bone marrow biopsy
19.5
71.9
59
36
Z51.5
ICD-10 Finland
Palliative care
17.7
71.7
62
42
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
27.6
71.2
50
21
NF3AA
NOMESCO Finland
Femur X-ray examination
20.7
70.3
56
32
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
792.5
68.4
65
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
+∞
63.5
59
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
13.1
62.7
65
60
TPX10
NOMESCO Finland
Implantation of vascular injection port
20.8
56.1
44
24
9180/3-C40.2
ICD-O-3
Osteosarcoma, NOS, of long bones of lower limb and associated joints
+∞
55.7
52
*
WW500
NOMESCO Finland
Blood transfusion
17.2
55.6
48
32
A04AA02
ATC
granisetron; systemic, transdermal
591.8
53.0
51
*
L03AA13
ATC
pegfilgrastim; parenteral
304.4
52.7
52
*
C40.21
ICD-10 Finland
Osteosarcoma of the long bones of the lower extremity
+∞
52.4
49
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
20.4
50.7
40
22
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
9.1
50.2
68
90
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
9.3
48.5
64
82
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
135.3
45.0
47
*
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
16.9
44.1
38
25
WZC00
NOMESCO Finland
Treatment plan or consultation
4.5
42.5
176
646
WF002
NOMESCO Finland
Radical radiotherapy
125.4
41.8
44
*
GD1AD
NOMESCO Finland
Thorax CT examination
8.8
41.6
57
76
C40.2
ICD-10 Finland
Malignant neoplasm: Long bones of lower limb
+∞
40.4
38
*
C40.20
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity without histology
+∞
40.4
38
*
C90.0
ICD-10 Finland
Multiple myeloma
433.9
39.9
39
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
4.4
39.9
231
1068
B01AB05
ATC
enoxaparin; parenteral
4.3
39.6
167
615
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
218.8
38.6
39
*
NG4AA
NOMESCO Finland
Lower leg X-ray examination
10.0
38.1
46
52
WX302
NOMESCO Finland
Thoracal epidural anesthesy
14.2
38.0
36
28
WX408
NOMESCO Finland
General anesthesy, balanced
4.3
37.9
146
501
WX402
NOMESCO Finland
General anaesthesia
4.7
37.9
118
345
A49.9
ICD-10 Finland
Bacterial infection, unspecified
5.9
37.7
79
165
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
37.1
35
*
C40.22
ICD-10 Finland
Chondrosarcoma of the long bones of the lower extremity
+∞
37.1
35
*
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
37.1
35
*
B01AB10
ATC
tinzaparin; parenteral
6.7
36.7
65
115
R4110
NOMESCO Finland
Physiotherapy
4.1
36.6
156
573
ZXE30
NOMESCO Finland
More than five and less than seven hours
9.8
36.6
45
52
N03AX16
ATC
[U] pregabalin
4.2
36.4
139
472
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
12.1
35.2
37
34
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
35.0
33
*
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
33.9
32
*
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
31.7
30
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
4.2
31.7
110
344
WX306
NOMESCO Finland
Lumbar epidural anesthesy
7.3
31.6
50
78
ZXE20
NOMESCO Finland
More than three and less than five hours
4.7
30.9
86
227
C40.29
ICD-10 Finland
Malignant tumor of the long bones of the lower extremity other or unspecified histology
+∞
30.7
29
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
29.6
28
*
NFR30
NOMESCO Finland
Extended excision of soft tissue tumour of hip or thigh
+∞
29.6
28
*
NE1DG
NOMESCO Finland
Pelvic, hip and femur very extensive MRI examination with high intensity magnet
72.6
29.5
33
5
ZX120
NOMESCO Finland
Intravenous
5.9
29.2
58
114
NER30
NOMESCO Finland
Extended excision of soft tissue tumour of pelvis
+∞
28.5
27
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
28.5
27
*
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
36.3
28.4
36
11
9220/3-C40.2
ICD-O-3
Chondrosarcoma, NOS, of long bones of lower limb and associated joints
+∞
27.5
26
*
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
+∞
27.5
26
*
WZC30
NOMESCO Finland
Teaching
4.4
26.4
79
219
NE1AA
NOMESCO Finland
Pelvis X-ray examination
5.3
25.8
58
127
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
7.8
24.2
35
49
JN4CD
NOMESCO Finland
Very extensive body CT
23.4
24.0
34
16
ZX090
NOMESCO Finland
Other technic of radiotherapy
134.2
23.9
25
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
23.2
22
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
23.2
22
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
+∞
22.1
21
*
C90.2
ICD-10 Finland
Extramedullary plasmacytoma
+∞
21.0
20
*
153
Kela drug reimbursment
Lenalidomid
+∞
21.0
20
*
ZXM10
NOMESCO Finland
Intraoperative use of conventional X-ray imaging
5.3
21.0
45
94
NK6AN
NOMESCO Finland
Total body bone isotope imaging
222.7
20.8
21
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
222.7
20.8
21
*
TPH07
NOMESCO Finland
Cathetrisation of artery
4.1
20.7
65
185
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
20.0
19
*
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
20.0
19
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
+∞
20.0
19
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
18.9
18
*
17071
ICD-8 Finland
Malignant neoplasm of bone, Lower limb, long bones
+∞
18.9
18
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
18.9
18
*
C41.49
ICD-10 Finland
Malignant tumor of the pelvic bones, sacrum and coccyx other or unspecified histology
+∞
18.9
18
*
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
5.8
18.2
35
66
NGB30
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part - connected prosthesis
55.6
18.2
21
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
70.4
17.9
20
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
+∞
17.9
17
*
329
Kela drug reimbursment
Lenalidomide
+∞
17.9
17
*
NGR30
NOMESCO Finland
Extensive or radikal excision of tumor of knee or lower leg
+∞
17.9
17
*
L04AX04
ATC
lenalidomide; oral
+∞
17.9
17
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
17.9
17
*
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
8.2
17.6
24
31
N02BF02
ATC
pregabalin; oral
5.5
17.6
36
72
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
13.6
17.0
29
23
B01AB04
ATC
dalteparin; parenteral
6.0
16.8
31
56
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
16.8
16
*
JN6DR
NOMESCO Finland
PET-CT of whole body metabolism
42.3
16.5
20
5
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
3.3
16.4
71
249
ZXE10
NOMESCO Finland
More than one and less than three hours
2.6
16.3
148
772
R50.9
ICD-10 Finland
Fever, unspecified
3.2
16.2
78
291
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
4.8
16.1
39
90
C41.42
ICD-10 Finland
Chondrosarcoma of the pelvic bones, sacrum and coccyx
+∞
15.7
15
*
9220/3-C41.3
ICD-O-3
Chondrosarcoma, NOS, of rib, sternum, clavicle and associated joints
+∞
15.7
15
*
GAE06
NOMESCO Finland
Excision of lesion of chest wall
+∞
15.7
15
*
C40.02
ICD-10 Finland
Chondrosarcoma of the scapula and long bones of the upper extremity
+∞
15.7
15
*
PJA12
NOMESCO Finland
Sentinel node biopsy
167.2
15.6
16
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
167.2
15.6
16
*
J01MA12
ATC
levofloxacin; systemic
3.0
15.4
83
330
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
2.6
14.9
125
623
QX3AT
NOMESCO Finland
Ultrasound guided biopsy of subcutaneous tissue
59.4
14.9
17
*
NG1DG
NOMESCO Finland
Knee and lower leg very extensive MRI examination with high intensity magnet
83.7
14.7
16
*
A04AD12
ATC
aprepitant; systemic
+∞
14.7
14
*
9101
FHL
Bone biopsy
+∞
14.7
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.7
14
*
C40.01
ICD-10 Finland
Osteosarcoma of the scapula and the long bones of the upper extremity
+∞
14.7
14
*
NFR20
NOMESCO Finland
Incomplete excision of soft tissue tumour of hip or thigh
156.3
14.6
15
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
3.3
14.4
63
221
D16.2
ICD-10 Finland
Benign neoplasm: Long bones of lower limb
28.6
14.4
19
7
NK6BN
NOMESCO Finland
Bone dynamic isotope examination
44.5
14.2
17
*
NB6AA
NOMESCO Finland
Humerus X-ray examination
7.0
14.2
22
33
JN6AD
NOMESCO Finland
CT of torso and neck
31.5
14.0
18
6
ZXA05
NOMESCO Finland
Left side
2.6
13.9
111
539
ZXD05
NOMESCO Finland
Urgent procedure
2.4
13.6
128
668
C40.00
ICD-10 Finland
Malignant tumor of the scapula and the long bones of the upper extremity without histology
+∞
13.6
13
*
L71
ICPC
Malignant neoplasm musculoskeletal
+∞
13.6
13
*
C41.4
ICD-10 Finland
Malignant neoplasm: Pelvic bones, sacrum and coccyx
+∞
13.6
13
*
9370/3-C41.4
ICD-O-3
Chordoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
13.6
13
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
13.6
13
*
NK1AT
NOMESCO Finland
Muscle biopsy with ultrasound guidance
+∞
13.6
13
*
ZXE00
NOMESCO Finland
One hour or less
2.4
13.4
153
869
M05BX04
ATC
denosumab; parenteral
5.1
13.3
29
61
J05AB01
ATC
aciclovir; systemic
2.6
13.1
91
411
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.7
13.1
83
358
R4190
NOMESCO Finland
Nutritional therapy
5.0
13.1
29
62
NJ3DA
NOMESCO Finland
Long bones of extremities X-ray examination
72.6
12.7
14
*
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
72.6
12.7
14
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
12.6
12
*
C41.32
ICD-10 Finland
Chondrosarcoma of the ribs, sternum and clavicle
+∞
12.6
12
*
A04AA55
ATC
palonosetron, combinations; systemic
+∞
12.6
12
*
NK6AT
NOMESCO Finland
Bone biopsy with ultrasound guidance
+∞
12.6
12
*
N02BE01
ATC
paracetamol; systemic, rectal
4.0
12.5
321
2593
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
3.6
12.5
44
134
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
134.6
12.5
13
*
HA1AA
NOMESCO Finland
X-ray mammography
9.2
12.2
25
29
NA2AA
NOMESCO Finland
Thoracal spine X-ray examination without contrast
6.0
12.1
22
39
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
3.7
12.1
41
122
ZXE05
NOMESCO Finland
Procedure duration 40 to 49 minutes
4.4
12.1
31
75
ZXE40
NOMESCO Finland
More than seven and less than nine hours
10.2
11.9
23
24
TPX15
NOMESCO Finland
Removal of vascular injection port
67.3
11.7
13
*
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.1
11.6
52
185
A79
ICPC
Malignancy NOS
+∞
11.5
11
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
11.5
11
*
9731/3-C41.2
ICD-O-3
Plasmacytoma, NOS, of vertebral column
+∞
11.5
11
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
11.5
11
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
11.5
11
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
123.9
11.5
12
*
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.6
11.3
75
329
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
2.3
11.3
111
584
NA2CG
NOMESCO Finland
Thoracal spine extensive MRI examination with high intensity magnet
20.9
11.2
16
8
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
26.0
11.2
15
6
WX002
NOMESCO Finland
Sedation and analgesia
2.5
11.2
82
377
N02AX02
ATC
tramadol; systemic, rectal
2.2
11.2
164
1013
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
8.7
11.0
23
28
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
44.8
11.0
13
*
ZXD10
NOMESCO Finland
Scheduled procedure
2.2
10.9
147
877
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
3.1
10.7
49
176
C41.22
ICD-10 Finland
Chondrosarcoma of the spine
+∞
10.5
10
*
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
+∞
10.5
10
*
9220/3-C41.4
ICD-O-3
Chondrosarcoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
10.5
10
*
C41.3
ICD-10 Finland
Malignant neoplasm: Ribs, sternum and clavicle
+∞
10.5
10
*
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
10.5
10
*
C40.11
ICD-10 Finland
Osteosarcoma of the short bones of the upper extremity
+∞
10.5
10
*
Z51.0
ICD-10 Finland
Radiotherapy session
+∞
10.5
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
+∞
10.5
10
*
9180/3-C40.0
ICD-O-3
Osteosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
10.5
10
*
C41.40
ICD-10 Finland
Pelvic bones, sacrum and coccyx
+∞
10.5
10
*
9680/3-C41.4
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
10.5
10
*
1707A
ICD-9 Finland
Malignant neoplasm of bone and articular cartilage, Long bones of lower limb[ALARAAJAN PITKIEN LUIDEN SYÖPÄ,OSTEOSARCOMA]
+∞
10.5
10
*
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
3.7
10.4
35
103
J04AB02
ATC
rifampicin; systemic
16.7
10.4
16
10
D70.89
ICD-10 Finland
Neutropenic splenomegaly
33.6
10.4
13
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
3.0
10.4
50
185
NFB60
NOMESCO Finland
Demanding prosthetic replacement of hip
19.5
10.3
15
8
NE1AD
NOMESCO Finland
Pelvis and hip bones CT examination
8.3
10.3
22
28
ZXE06
NOMESCO Finland
Procedure duration 50 to 59 minutes
3.8
10.0
32
91
A06AH03
ATC
naloxegol; oral
41.3
10.0
12
*
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
3.6
9.9
34
102
NGR20
NOMESCO Finland
Intralesional or marginal excision of tumor of knee or lower leg
56.6
9.7
11
*
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
7.9
9.6
21
28
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
4.4
9.5
24
57
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
4.2
9.5
26
66
A02BC02
ATC
pantoprazole; systemic
2.1
9.5
235
1729
NER20
NOMESCO Finland
Incomplete excision of soft tissue tumour of pelvis
102.7
9.5
10
*
NF3AD
NOMESCO Finland
Femur CT
31.0
9.5
12
*
T84.5
ICD-10 Finland
Infection and inflammatory reaction due to internal joint prosthesis
12.8
9.5
16
13
NG1BG
NOMESCO Finland
Knee and lower leg MRI examination with high intensity magnet
4.7
9.4
22
49
C40.91
ICD-10 Finland
Osteosarcoma in unspecified locations in the bones and articular cartilage of the extremities
+∞
9.4
9
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
9.4
9
*
WX2DD
NOMESCO Finland
Low-dose CT of skeleton in whole body
+∞
9.4
9
*
9220/3-C40.0
ICD-O-3
Chondrosarcoma, NOS, of long bones of upper limb, scapula and associated joints
+∞
9.4
9
*
WW409
NOMESCO Finland
Other aferesis
+∞
9.4
9
*
NBR30
NOMESCO Finland
Extensive or radical excision of soft tissue tumour of shoulder or upper arm
+∞
9.4
9
*
9680/3-C41.2
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of vertebral column
+∞
9.4
9
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
9.4
9
*
159
Kela drug reimbursment
Pazopanib
+∞
9.4
9
*
C41.82
ICD-10 Finland
Overall chondrosarcoma in bone and articular cartilage
+∞
9.4
9
*
GDB10
NOMESCO Finland
Wedge resection of lung
+∞
9.4
9
*
Z85.8
ICD-10 Finland
Personal history of malignant neoplasms of other organs and systems
+∞
9.4
9
*
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
3.3
9.4
37
121
R52.0
ICD-10 Finland
Acute pain
4.6
9.2
22
50
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
16.1
9.1
14
9
NGA20
NOMESCO Finland
Exploration of soft tissue knee or lower leg, open
37.7
9.1
11
*
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
37.7
9.1
11
*
L28
ICPC
Limited function/disability (L)
2.4
9.0
75
363
NF1AA
NOMESCO Finland
Hip X-ray examination
2.9
8.9
43
159
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
3.1
8.9
40
142
ZXA00
NOMESCO Finland
Right side
2.1
8.7
103
575
2392A
ICD-9 Finland
Neoplasm of unspecified nature, Bone, soft tissue and skin
51.3
8.7
10
*
NBR20
NOMESCO Finland
Intralesional or marginal excision of soft tissue tumour of shoulder or upper arm
51.3
8.7
10
*
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
12.0
8.7
15
13
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.7
8.6
48
192
D48.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Neoplasm of uncertain or unknown behaviour, unspecified
7.7
8.6
19
26
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.3
8.4
74
366
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
92.2
8.4
9
*
QX4AT
NOMESCO Finland
Ultrsound guided needle biopsy of skin
92.2
8.4
9
*
R4120
NOMESCO Finland
Occupational therapy
3.2
8.4
34
113
C50.40
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication
+∞
8.4
8
*
WW402
NOMESCO Finland
Leucoferesis
+∞
8.4
8
*
D16.8
ICD-10 Finland
Benign neoplasm: Pelvic bones, sacrum and coccyx
+∞
8.4
8
*
9731/3-C41.3
ICD-O-3
Plasmacytoma, NOS, of rib, sternum, clavicle and associated joints
+∞
8.4
8
*
M90.7*C90.0
ICD-10 Finland
Pathological fracture in multiple myeloma
+∞
8.4
8
*
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
+∞
8.4
8
*
C40.10
ICD-10 Finland
Malignant tumor of the upper limb's short bones without histology
+∞
8.4
8
*
HAC20
NOMESCO Finland
Total mastectomy
+∞
8.4
8
*
NFA20
NOMESCO Finland
Exploration of hip joint or femur
+∞
8.4
8
*
C41.41
ICD-10 Finland
Osteosarcoma of the pelvic bones, sacrum and coccyx
+∞
8.4
8
*
9220/3-C41.0
ICD-O-3
Chondrosarcoma, NOS, of bones of skull and face and associated joints
+∞
8.4
8
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
8.4
8
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
8.4
8
*
NEA20
NOMESCO Finland
Exploration of soft tissue of pelvis,v
+∞
8.4
8
*
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
4.6
8.3
20
46
F43.22
ICD-10 Finland
Adaptation disorder with mixed anxiety and depression
4.6
8.3
20
46
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
4.0
8.1
23
60
M04AA01
ATC
allopurinol; systemic
2.5
8.1
56
249
WX600
NOMESCO Finland
Single shot through catheter
22.6
8.1
11
5
AA1AA
NOMESCO Finland
Head X-ray examination
11.2
7.9
14
13
NB1CG
NOMESCO Finland
Shoulder and humerus extensive MRI examination with high intensity magnet
6.6
7.8
19
30
ZZR30
NOMESCO Finland
Flap of muscle
46.0
7.7
9
*
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.1
7.7
33
114
ZX112
NOMESCO Finland
Subcutaneous
9.2
7.6
15
17
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
3.0
7.5
35
127
ZX121
NOMESCO Finland
Central venous catheter
81.8
7.4
8
*
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
81.8
7.4
8
*
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
81.8
7.4
8
*
ZXX04
NOMESCO Finland
Extent of procedure, 4 units
81.8
7.4
8
*
J01FF01
ATC
clindamycin; systemic
2.0
7.4
92
520
J05AB11
ATC
valaciclovir; oral
2.3
7.4
58
273
B03XA02
ATC
darbepoetin alfa; parenteral
9.7
7.3
14
15
WX1CG
NOMESCO Finland
Extensive total body MRI with high intensity magnet
+∞
7.3
7
*
C49.29
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of lower extremity including hip other or unspecified tumor
+∞
7.3
7
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
7.3
7
*
Z89.6
ICD-10 Finland
Acquired absence of leg above knee
+∞
7.3
7
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
7.3
7
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
+∞
7.3
7
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
7.3
7
*
C41.09
ICD-10 Finland
Malignant tumor of the skull or facial bones other or unspecified histology
+∞
7.3
7
*
YNB10
NOMESCO Finland
Collection of stem cells for transplant
+∞
7.3
7
*
GAE23
NOMESCO Finland
Resection of chest wall and prosthetic repair
+∞
7.3
7
*
L01BC06
ATC
capecitabine; oral
+∞
7.3
7
*
C41.20
ICD-10 Finland
Malignant tumor of the spine without histology
+∞
7.3
7
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
7.3
7
*
C41.2
ICD-10 Finland
Malignant neoplasm: Vertebral column
+∞
7.3
7
*
SPAT1153
SPAT
Removal of sutures
1.9
7.3
111
674
NB1DG
NOMESCO Finland
Shoulder and humerus very extensive MRI examination with high intensity magnet
16.2
7.3
11
7
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
3.5
7.3
25
75
NF3BA
NOMESCO Finland
Femur extensive X-ray examination
30.7
7.2
9
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.6
7.0
42
174
H02AB09
ATC
hydrocortisone; systemic
5.9
6.9
18
32
504
Kela drug reimbursment
Conditions requiring daily forced enteral nutrition
11.2
6.8
12
11
TPH04
NOMESCO Finland
Cathetrisation of vein
2.1
6.8
78
427
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
40.9
6.8
8
*
A41.9
ICD-10 Finland
Sepsis, unspecified
3.9
6.7
20
54
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.1
6.7
28
95
H02AB06
ATC
prednisolone; systemic
1.8
6.6
158
1099
EE1AA
NOMESCO Finland
X-ray of upper jaw or palate
71.1
6.4
7
*
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
71.1
6.4
7
*
NFQ48
NOMESCO Finland
Revision of exarticulation or amputation stump of hip or femur
71.1
6.4
7
*
9102
FHL
Trepanation or removal of the local bone process
14.7
6.4
10
7
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
6.4
150
1035
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
8.4
6.4
13
16
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
6.2
6.4
16
27
L02BG04
ATC
letrozole; oral
11.3
6.3
11
10
QB9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in torso, unspecified
18.4
6.3
9
5
Z73.3
ICD-10 Finland
Stress, not elsewhere classified
18.4
6.3
9
5
343
Kela drug reimbursment
Pazopanib
+∞
6.3
6
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
+∞
6.3
6
*
9731/3-C41.9
ICD-O-3
Plasmacytoma, NOS, of bone, NOS
+∞
6.3
6
*
C41.0
ICD-10 Finland
Malignant neoplasm: Bones of skull and face
+∞
6.3
6
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
6.3
6
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
+∞
6.3
6
*
HA003
NOMESCO Finland
Radiotherapy after partial ablation of mammary gland
+∞
6.3
6
*
C40.12
ICD-10 Finland
Chondrosarcoma of the short bones of the upper extremity
+∞
6.3
6
*
C41.06
ICD-10 Finland
Chondrosarcoma of the skull or facial bones except maxilla
+∞
6.3
6
*
WB133
NOMESCO Finland
Very demanding adjuvant cytostatic therapy
+∞
6.3
6
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
6.3
6
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
6.3
6
*
C40.23
ICD-10 Finland
Ewing's sarcoma in the long bones of the lower extremity
+∞
6.3
6
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
+∞
6.3
6
*
C49.20
ICD-10 Finland
Malignant tumor of connective tissue and soft tissue of the lower extremity including the hip without histology
+∞
6.3
6
*
C83.39
ICD-10 Finland
Diffuse non-Hodgkin's large cell lymphoma UNS
+∞
6.3
6
*
NJ3DG
NOMESCO Finland
Very extensive MRI examination of extremities with high intensity magnet
+∞
6.3
6
*
C40.0
ICD-10 Finland
Malignant neoplasm: Scapula and long bones of upper limb
+∞
6.3
6
*
NK6DT
NOMESCO Finland
Bone biopsy with MRI guidance
+∞
6.3
6
*
C83.9
ICD-10 Finland
Non-follicular (diffuse) lymphoma, unspecified
+∞
6.3
6
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
6.3
6
*
C41.29
ICD-10 Finland
Malignant tumor of the spine other or unspecified histology
+∞
6.3
6
*
9731/3-C41.4
ICD-O-3
Plasmacytoma, NOS, of pelvic bones, sacrum, coccyx and associated joints
+∞
6.3
6
*
C40.93
ICD-10 Finland
Malignant tumor in unspecified locations in the bones and articular cartilage of the extremities
+∞
6.3
6
*
NGR40
NOMESCO Finland
Extensive excision of tumor of knee or lower leg with repair
+∞
6.3
6
*
C41.00
ICD-10 Finland
Malignant tumor of the skull or facial bone without histology
+∞
6.3
6
*
NBA20
NOMESCO Finland
Exploration of joint of shoulder or upper arm, open
+∞
6.3
6
*
XX1AD
NOMESCO Finland
Other CT-examination
+∞
6.3
6
*
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
6.3
6
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
6.3
6
*
ZX108
NOMESCO Finland
Inhalation
27.2
6.3
8
*
NG4AD
NOMESCO Finland
Lower leg CT
27.2
6.3
8
*
X59
ICD-10 Finland
Exposure to unspecified factor
2.0
6.2
76
426
S18
ICPC
Laceration/cut
1.8
6.1
156
1099
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
8.8
6.1
12
14
Z31.6
ICD-10 Finland
General counselling and advice on procreation
10.3
6.1
11
11
NH1AA
NOMESCO Finland
Ankle X-ray examination without contrast
2.7
6.1
33
130

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
110
66
23.88
138.28
1.7
1.4
—
—
—
0
0
69
68
12.40
63.80
10.5
1.3
39.45
43.38
mg/l
0.18
60
56
69
68
12.40
63.80
10.4
1.3
33.44
31.88
mg/l
0.03
60
57
60
48
14.89
63.11
10.8
1.2
—
—
—
0
0
68
67
12.36
62.85
10.3
1.3
6.97
0.86
ratio
—
5
6
41
23
20.07
51.50
2.9
1.0
—
—
—
0
0
85
161
6.66
45.32
7.8
1.3
—
—
—
0
0
166
571
4.64
44.06
4.8
2.1
—
—
—
0
0
202
807
4.57
43.81
3.2
1.6
—
—
—
0
0
193
752
4.50
43.15
4.8
2.1
—
—
—
0
0
258
1270
4.96
41.41
15.6
4.0
9.53
11.91
umol/l
5.53
251
1201
234
1072
4.59
41.40
8.5
4.2
34.02
36.05
g/l
5.71
226
998
41
36
12.77
40.31
3.9
1.3
—
—
—
0
0
175
668
4.25
39.47
7.7
3.8
—
—
—
0
0
238
1142
4.41
38.54
16.5
6.4
1.21
1.21
mmol/l
0.53
223
1027
248
1259
4.35
36.25
19.5
6.5
1.20
1.21
mmol/l
1.56
215
1099
235
1151
4.19
36.13
4.7
2.4
—
—
—
0
0
77
174
5.39
33.46
1.3
1.5
—
—
—
0
0
65
126
6.11
33.35
4.4
1.7
3.99
2.63
ug/l
0.68
48
95
268
1501
4.38
32.53
26.2
6.6
3.96
4.25
e9/l
0.48
242
1311
179
797
3.56
30.26
9.6
2.0
2.34
2.35
mmol/l
0.21
167
669
246
1345
3.81
29.85
11.4
5.5
0.56
0.58
e9/l
0.91
221
1179
232
1228
3.65
29.49
14.0
6.1
—
—
—
0
0
245
1348
3.74
29.17
11.5
5.5
0.03
0.04
e9/l
4.09
219
1184
248
1382
3.75
28.79
11.5
5.6
1.58
1.88
e9/l
7.82
225
1235
248
1395
3.69
28.07
13.3
5.9
0.19
0.20
e9/l
0.57
224
1235
227
1217
3.48
27.59
11.5
5.8
0.56
0.68
%
2.95
222
1140
95
294
4.07
27.43
10.8
9.0
1.12
1.34
mmol/l
0.23
78
240
112
389
3.77
27.38
2.5
1.9
—
—
—
0
0
29
27
11.62
27.23
1.7
1.8
—
—
—
0
0
231
1264
3.45
26.89
11.5
5.7
2.80
3.05
%
0.71
226
1185
58
124
5.41
26.56
14.2
10.2
24.80
24.71
mmol/l
0.07
58
119
231
1272
3.41
26.45
11.9
6.0
8.95
8.48
%
1.52
226
1196
304
2015
4.95
25.71
17.8
5.3
93.52
78.69
u/l
2.74
297
1853
74
201
4.40
25.33
1.4
1.1
—
—
—
0
0
24
0
+∞
25.31
24.8
0.0
0.33
—
umol/l
—
24
0
232
1305
3.32
25.13
11.7
5.8
24.32
28.52
%
6.44
227
1234
94
307
3.82
24.93
1.4
1.5
—
—
—
0
0
230
1292
3.29
24.88
11.2
5.7
59.66
56.84
%
2.64
224
1224
258
1615
3.29
21.94
11.9
4.7
6.52
6.71
mmol/l
0.95
249
1500
152
721
2.96
21.36
9.0
3.2
7.40
7.40
ph
0.30
35
106
64
183
4.06
20.23
5.4
4.3
1.63
0.80
%
2.24
44
49
60
164
4.21
20.15
5.1
4.3
0.93
0.39
%
1.83
40
38
98
375
3.24
19.89
1.5
1.6
—
—
—
0
0
110
451
3.10
19.84
6.4
2.0
2.46
2.42
mmol/l
2.55
103
379
58
157
4.23
19.72
14.8
9.5
0.80
0.69
%
1.06
58
157
61
172
4.09
19.63
28.0
9.2
25.00
25.09
mmol/l
0.07
61
172
58
158
4.20
19.55
14.7
9.5
1.29
1.44
%
0.75
58
158
210
1235
2.76
18.86
15.9
16.3
1.21
1.34
inr
1.31
56
336
30
20
16.29
18.81
2.9
2.0
0.36
2.80
g/24h
—
14
10
144
706
2.77
18.47
3.8
2.4
6221.52
9766.94
umol/l
0.40
134
622
131
617
2.80
18.09
22.0
5.0
—
—
—
0
0
25
11
24.35
18.01
3.4
3.0
33.14
37.09
%
0.33
25
11
23
8
30.64
17.65
2.5
1.0
—
—
—
0
0
100
420
2.94
16.98
5.6
2.1
29.57
29.87
s
0.22
95
406
66
219
3.48
16.64
4.7
2.4
74.92
67.89
e9/l
0.92
53
169
57
173
3.74
16.42
5.7
4.4
0.22
0.08
%
0.87
36
37
47
129
4.05
15.57
11.2
14.2
—
—
—
0
0
68
244
3.22
15.05
18.6
8.5
—
—
—
0
0
141
746
2.49
14.81
3.8
3.1
0.71
0.41
e6/l
0.26
107
555
36
84
4.66
14.67
19.1
9.0
1.21
1.50
mg/l
1.42
36
79
138
727
2.49
14.59
3.7
3.1
—
—
—
0
0
79
318
2.92
14.27
1.9
1.7
—
—
—
0
0
64
232
3.15
13.87
23.8
6.8
1.13
1.41
mmol/l
2.07
64
224
80
331
2.84
13.70
18.5
5.7
104.33
104.54
mmol/l
0.13
80
331
52
167
3.48
13.69
6.0
4.4
0.42
0.03
%
0.43
31
29
127
661
2.45
13.62
1.5
1.4
—
—
—
0
0
191
1213
2.27
12.63
22.9
7.7
0.00
0.00
e9/l
0.45
160
986
143
816
2.27
12.14
4.4
3.2
51.90
122.05
e6/l
0.41
112
620
17
8
22.24
12.12
1.2
1.0
—
—
—
0
0
56
212
2.96
11.16
5.2
5.5
7.45
7.39
ph
—
8
19
18
13
14.52
11.09
1.2
1.5
—
—
—
0
0
69
300
2.62
10.56
4.2
2.7
10.75
8.13
umol/l
0.18
64
262
102
533
2.29
10.43
4.6
2.9
567.21
566.63
mosm/kgh2o
0.01
95
443
104
556
2.24
10.02
3.4
2.5
5.31
5.19
e6/l
0.05
96
489
152
945
2.08
9.90
5.8
3.8
62.94
86.45
e6/l
0.37
119
664
92
478
2.26
9.43
1.5
1.9
—
—
—
0
0
53
216
2.71
9.16
2.4
2.6
0.19
0.21
g/l
1.03
53
195
264
2051
2.18
8.94
6.0
4.1
16.82
10.80
mm/h
5.45
256
1888
18
21
8.97
8.91
2.7
3.8
—
—
—
0
0
28
79
3.77
8.87
1.8
1.9
10.65
7.32
u/l
0.51
17
71
20
44
4.76
8.70
1.4
1.3
—
—
—
0
0
12
6
20.64
8.52
2.0
2.8
0.02
0.14
e9/l
—
12
6
244
1858
2.04
8.47
5.4
4.2
—
—
—
0
0
8
0
+∞
8.36
1.0
0.0
—
—
—
0
0
18
39
4.81
7.97
6.1
3.7
60.39
59.28
%
0.12
18
39
15
16
9.74
7.86
4.7
2.1
700.30
477.64
e6/l
—
10
11
66
324
2.28
7.63
3.3
2.5
22.44
24.66
%
0.49
61
287
330
2894
3.58
7.60
40.8
14.6
139.17
139.77
mmol/l
3.85
324
2810
330
2897
3.56
7.52
41.3
14.7
3.93
3.99
mmol/l
2.90
323
2808
15
18
8.65
7.39
1.1
1.3
—
—
—
0
0
19
47
4.22
7.17
3.3
2.4
14.39
16.37
%
1.19
14
23
30
102
3.12
7.16
5.6
6.0
8.58
8.81
kpa
0.28
30
95
123
778
1.90
7.12
4.0
3.0
—
—
—
0
0
127
814
1.88
7.04
4.5
3.1
1228.56
1366.22
ng/l
0.15
117
680
322
2809
2.89
7.02
36.5
12.0
29.16
23.13
mg/l
2.55
295
2117
68
350
2.17
6.98
3.5
2.4
2.25
2.33
g/l
0.49
68
327
243
1910
1.90
6.92
4.3
3.8
—
—
—
0
0
79
439
2.03
6.61
4.1
3.0
3.48
1.88
e6/l
0.68
40
242
15
23
6.76
6.40
3.3
1.4
31.20
33.70
pg
0.93
15
23
15
24
6.48
6.23
1.8
3.2
—
—
—
0
0
39
165
2.54
6.23
5.5
5.8
—
—
—
0
0
16
39
4.25
6.15
5.4
3.2
3.70
4.64
e9/l
1.02
16
39
12
14
8.83
6.10
2.7
1.2
—
—
—
0
0
125
841
1.76
5.68
3.3
2.3
51.47
61.88
u/l
0.99
120
779
105
679
1.78
5.43
2.1
2.3
2.66
2.98
mg/l
1.02
90
580
14
25
5.79
5.43
3.4
1.3
—
—
—
0
0
17
48
3.67
5.39
2.9
2.4
—
—
—
0
0
92
578
1.80
5.22
3.9
1.8
1.41
1.08
mg/l
0.60
75
434
11
15
7.53
5.18
2.5
3.1
50.00
48.06
%
—
5
10
149
1079
1.66
5.04
4.5
3.7
27.34
41.35
ng/l
1.44
124
746
38
176
2.30
5.00
4.7
7.5
—
—
—
0
0
8
7
11.66
4.80
1.1
1.0
—
—
—
0
0
55
300
1.99
4.78
23.2
4.3
2.28
1.79
mmol/l
0.61
49
242
47
242
2.09
4.78
10.4
3.5
—
—
—
0
0
10
15
6.83
4.50
1.1
1.1
—
—
—
0
0
8
9
9.06
4.30
2.4
1.3
13.38
12.01
ug/l
—
8
9
91
602
1.69
4.22
3.7
1.3
2.33
2.36
g/l
0.04
71
353
327
2998
2.44
4.19
23.2
8.6
28.35
26.45
u/l
0.81
320
2875
14
35
4.12
4.15
1.4
1.1
—
—
—
0
0
18
63
2.96
4.12
1.4
1.5
20245.67
9759.59
e6/l
0.86
12
49
169
1313
1.56
4.01
5.5
3.5
0.00
0.01
estimate
0.74
40
232
9
14
6.57
4.01
1.2
1.1
—
—
—
0
0
17
59
2.98
3.95
1.2
1.4
—
—
—
0
0
19
71
2.77
3.89
1.4
1.1
—
—
—
0
0
168
1313
1.54
3.82
7.2
4.9
0.00
0.00
estimate
-0.00
39
214
13
35
3.82
3.63
1.7
1.5
—
—
—
0
0
144
1098
1.53
3.62
2.5
2.6
76.80
76.24
nmol/l
0.09
132
972
150
1161
1.51
3.48
3.3
2.7
392.56
115.04
ug/l
1.16
143
1069
12
32
3.85
3.42
1.5
1.3
—
—
—
0
0
16
59
2.79
3.37
1.6
1.2
—
—
—
0
0
13
38
3.51
3.35
1.1
1.1
—
—
—
0
0
45
259
1.85
3.34
4.1
1.9
370.22
364.21
nmol/l
0.09
45
240
6
7
8.69
3.27
1.2
1.0
—
—
—
0
0
166
1330
1.47
3.17
5.5
3.5
0.00
0.00
estimate
-0.00
39
210
14
50
2.88
3.12
4.4
3.8
—
—
—
0
0
53
329
1.72
3.07
1.5
1.5
—
—
—
0
0
320
2967
1.95
3.03
27.8
11.3
—
—
—
0
0
16
63
2.61
3.00
40.4
3.4
—
—
—
0
0
28
143
2.04
2.94
26.4
2.5
0.61
0.66
%
0.30
28
143
11
32
3.51
2.92
2.0
1.8
3.19
120.74
u/ml
0.50
11
32
78
542
1.57
2.90
3.7
3.8
32.90
541.82
ng/l
2.77
63
425
95
692
1.51
2.85
6.2
3.6
0.00
0.00
estimate
-0.00
38
211
8
18
4.52
2.81
1.3
1.1
—
—
—
0
0
29
154
1.96
2.75
1.2
1.2
—
—
—
0
0
23
112
2.13
2.74
7.0
4.8
—
—
—
0
0
28
148
1.97
2.69
26.4
2.6
1.27
1.23
%
0.10
28
148
17
73
2.40
2.69
3.4
2.5
—
—
—
0
0
19
87
2.25
2.62
2.5
1.8
16.21
22.00
iu/l
0.34
13
77
5
7
7.23
2.55
6.4
1.4
8.56
28.43
u/l
—
5
7
6
11
5.53
2.55
1.0
1.3
—
—
—
0
0
36
212
1.78
2.51
2.4
2.3
10.41
15.36
nmol/l
2.66
28
195
9
26
3.52
2.50
69.0
2.7
8.31
12.20
%
—
9
26
8
21
3.87
2.47
1.3
1.0
—
—
—
0
0
84
613
1.49
2.47
4.8
3.5
—
—
—
0
0
334
3174
2.22
2.45
53.8
17.6
37.49
40.56
%
12.47
315
2952
10
32
3.19
2.45
1.4
1.9
—
—
—
0
0
20
97
2.13
2.42
4.3
3.2
0.16
0.24
g/l
—
10
37
9
27
3.39
2.41
1.4
1.1
—
—
—
0
0
334
3177
2.19
2.39
51.1
17.5
4.25
4.56
e12/l
16.98
323
3078
334
3177
2.19
2.39
51.1
17.5
6.76
6.67
e9/l
0.12
323
3079
11
39
2.88
2.36
2.9
3.9
—
—
—
0
0
14
59
2.43
2.32
46.3
2.4
53.24
66.85
%
1.19
14
59
103
791
1.43
2.32
5.3
3.9
—
—
—
0
0
38
236
1.68
2.22
2.2
2.0
41.22
31.53
u/l
0.49
27
195
333
3176
2.06
2.16
51.3
17.5
245.01
247.38
e9/l
0.24
322
3086
6
14
4.34
2.16
1.0
1.4
—
—
—
0
0
208
1812
1.37
2.14
3.4
3.1
55.74
45.48
u/l
0.94
199
1703
5
10
5.05
2.07
1.2
1.0
—
—
—
0
0
34
209
1.69
2.07
6.7
3.1
—
—
—
0
0
36
225
1.67
2.06
4.3
3.0
—
—
—
0
0
8
26
3.12
2.02
1.3
1.2
—
—
—
0
0
9
32
2.86
2.01
1.6
1.2
—
—
—
0
0
12
51
2.40
1.97
1.2
1.2
—
—
—
0
0
132
1085
1.35
1.93
4.6
3.3
6.20
5.67
ph
—
10
79
16
80
2.05
1.83
3.4
1.7
—
—
—
0
0
14
67
2.14
1.78
1.6
1.3
276.14
308.64
ug/g
—
7
38
38
252
1.57
1.75
1.5
1.3
—
—
—
0
0
86
672
1.37
1.71
1.6
1.5
19.32
20.56
nmol/l
0.35
79
579
17
302
0.54
1.71
1.3
1.6
—
—
—
0
0
77
980
0.73
1.71
2.9
2.9
—
—
—
0
0
8
173
0.45
1.63
1.0
1.2
—
—
—
0
0
133
1117
1.31
1.62
1.9
2.0
90.50
94.99
pmol/l
0.40
75
572
13
63
2.10
1.62
3.6
3.9
7.40
7.41
ph
0.26
13
56
7
26
2.73
1.59
1.0
1.2
—
—
—
0
0
6
20
3.03
1.58
1.3
1.2
—
—
—
0
0
11
50
2.24
1.58
1.5
2.0
5.15
5.34
mmol/24h
0.07
11
44
5
15
3.37
1.53
2.4
1.4
0.60
3.88
u/field
—
5
8
233
2118
1.30
1.52
4.6
3.7
14.80
14.85
pmol/l
0.10
211
1919
91
731
1.33
1.51
5.4
3.1
—
—
—
0
0
8
168
0.46
1.51
1.4
1.4
—
—
—
0
0
105
864
1.31
1.47
2.7
2.2
610.54
292.76
u/l
0.42
99
811
7
28
2.53
1.46
2.0
2.5
—
—
—
0
0
17
95
1.83
1.46
1.3
1.2
—
—
—
0
0
5
16
3.15
1.44
2.8
1.1
126.60
173.17
mmol/24h
—
5
16
11
53
2.11
1.40
3.9
3.8
6.88
8.10
kpa
0.90
11
53
11
53
2.11
1.40
3.9
3.8
5.15
5.16
kpa
0.02
11
53
15
258
0.56
1.38
1.3
1.3
—
—
—
0
0
5
17
2.97
1.36
1.4
1.7
—
—
—
0
0
5
17
2.97
1.36
2.2
2.2
—
—
—
0
0
16
91
1.79
1.31
1.3
1.1
—
—
—
0
0
5
18
2.80
1.29
1.8
1.4
10.00
10.11
mmol/l
—
5
18
120
1023
1.26
1.25
4.2
3.8
3.30
1.94
ug/l
0.69
108
901
6
25
2.42
1.25
2.5
2.0
—
—
—
0
0
14
79
1.80
1.18
1.5
1.3
367.93
476.01
mg/l
0.85
14
73
5
20
2.52
1.15
1.8
1.5
2.22
2.08
mmol/l
—
5
20
7
30
2.36
1.13
4.7
1.7
81.07
90.97
%
—
7
30
7
33
2.14
1.06
1.7
4.2
6.54
6.92
mmol/l
—
7
24
15
90
1.70
1.05
1.4
1.7
—
—
—
0
0
5
23
2.19
0.98
1.0
1.4
—
—
—
0
0
0
31
0.00
0.97
0.0
1.0
—
2.19
—
0
16
12
70
1.74
0.93
1.3
1.2
3.71
3.83
mmol/l
0.16
12
64
63
518
1.26
0.89
1.7
1.7
1447.68
1194.05
nmol/l
0.89
47
387
14
87
1.63
0.89
4.2
4.6
3.99
3.94
mmol/l
0.12
14
87
8
43
1.88
0.88
2.5
1.3
161.13
60.17
pmol/l
—
8
43
245
2584
0.83
0.87
5.6
5.9
39.24
40.10
mmol/mol
0.73
223
2400
13
81
1.63
0.82
4.8
4.0
—
—
—
0
0
0
24
0.00
0.79
0.0
1.3
—
—
—
0
0
21
289
0.71
0.77
1.2
1.5
—
—
—
0
0
0
28
0.00
0.76
0.0
1.1
—
6.27
—
0
12
35
442
0.77
0.74
1.1
1.3
19.41
9.89
u/ml
—
8
178
271
2592
1.20
0.73
5.3
4.4
2.00
1.90
mu/l
0.55
247
2367
7
40
1.77
0.71
1.0
1.1
—
—
—
0
0
7
40
1.77
0.71
1.0
1.1
—
—
—
0
0
5
26
1.94
0.71
1.4
2.8
—
—
—
0
0
73
635
1.19
0.62
5.7
3.5
1.02
1.02
kg/l
0.32
14
85
6
36
1.68
0.57
1.0
1.1
—
—
—
0
0
273
2818
0.86
0.54
4.4
5.0
2.63
2.71
mmol/l
0.81
246
2610
67
760
0.85
0.53
1.8
1.7
1.30
1.40
mmol/l
0.47
61
641
20
152
1.33
0.53
3.1
3.3
—
—
—
0
0
268
2769
0.86
0.53
4.1
4.5
4.43
4.58
mmol/l
1.62
244
2573
266
2749
0.86
0.52
4.1
4.4
1.37
1.45
mmol/l
2.06
239
2539
7
48
1.47
0.47
1.1
1.1
—
—
—
0
0
10
69
1.46
0.44
1.5
2.0
—
—
—
0
0
40
465
0.84
0.43
1.2
1.3
70.24
35.77
iu/ml
0.29
12
151
6
95
0.63
0.42
3.7
1.6
—
—
—
0
0
0
15
0.00
0.41
0.0
1.2
—
—
—
0
0
0
15
0.00
0.41
0.0
1.1
—
0.29
—
0
6
7
104
0.67
0.40
4.0
9.1
—
—
—
0
0
10
136
0.73
0.38
2.1
1.4
—
—
—
0
0
10
136
0.73
0.38
2.9
1.4
—
—
—
0
0
10
136
0.73
0.38
2.1
1.4
—
—
—
0
0
16
202
0.78
0.38
1.3
1.6
—
—
—
0
0
78
853
0.89
0.38
3.7
3.2
4851.60
134.45
mg/l
1.85
50
560
10
135
0.73
0.37
2.1
1.4
—
—
—
0
0
42
368
1.16
0.35
1.4
1.2
—
—
—
0
0
6
43
1.40
0.35
2.0
2.2
—
—
—
0
0
6
44
1.37
0.34
2.0
2.1
4.12
4.08
mmol/l
—
6
44
6
44
1.37
0.34
2.0
2.1
107.17
105.73
mmol/l
—
6
44
10
130
0.76
0.30
2.1
1.4
—
—
—
0
0
63
576
1.11
0.30
2.4
2.6
0.98
0.73
ug/l
0.76
45
370
8
107
0.74
0.29
1.3
1.1
—
—
—
0
0
84
900
0.91
0.28
3.1
3.8
9.33
8.23
mg/mmol
0.10
48
588
28
244
1.16
0.26
1.5
1.7
—
—
—
0
0
18
209
0.85
0.21
2.7
2.5
—
15.32
—
0
11
0
11
0.00
0.21
0.0
1.4
—
—
—
0
0
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
0
10
0.00
0.21
0.0
9.3
—
26.31
—
0
10
0
12
0.00
0.21
0.0
1.2
—
7.91
—
0
12
0
13
0.00
0.21
0.0
2.0
—
—
—
0
0
0
13
0.00
0.21
0.0
1.4
—
151.46
—
0
13
0
13
0.00
0.21
0.0
1.4
—
1.54
—
0
13
17
147
1.16
0.18
2.5
2.3
—
—
—
0
0
13
111
1.18
0.16
1.6
1.3
—
—
—
0
0
10
119
0.84
0.15
1.0
1.1
—
—
—
0
0
65
684
0.94
0.15
1.2
1.4
1.85
1.95
u/ml
0.04
19
179
40
375
1.08
0.13
1.1
1.4
240.00
542.73
titre
—
6
88
261
2640
0.95
0.11
3.8
4.0
1.24
1.29
mmol/l
0.63
235
2429
60
574
1.05
0.11
1.6
1.8
422.83
423.01
pmol/l
0.00
46
478
20
183
1.10
0.10
5.8
2.6
—
—
—
0
0
6
54
1.11
0.09
5.8
3.0
—
—
—
0
0
10
88
1.14
0.08
1.4
1.7
219.30
299.66
mu/l
—
10
80
7
67
1.05
0.08
3.7
1.6
—
—
—
0
0
6
71
0.84
0.07
1.0
1.2
—
—
—
0
0
12
108
1.12
0.07
1.8
1.4
1.08
1.18
g/l
0.91
12
103
8
78
1.03
0.07
1.4
1.1
—
—
—
0
0
9
103
0.87
0.06
2.2
1.5
—
—
—
0
0
23
242
0.95
0.05
1.2
1.2
—
—
—
0
0
12
111
1.08
0.04
1.9
1.6
—
—
—
0
0
270
2710
0.98
0.02
4.5
4.5
5.83
5.97
mmol/l
1.22
243
2452
38
372
1.02
0.01
3.1
2.3
165.90
97.23
ug/g
0.80
29
286
27
264
1.02
0.00
1.4
1.4
—
—
—
0
0
10
102
0.98
0.00
1.3
1.7
—
—
—
0
0
95
951
1.00
0.00
2.9
3.2
7.56
7.73
mmol/l
0.12
76
818
0
9
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.9
—
347.86
—
0
7
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
-0.00
0.0
11.4
—
1.20
—
0
7
0
5
0.00
-0.00
0.0
1.0
—
23.52
—
0
5
0
7
0.00
-0.00
0.0
1.6
—
14.11
—
0
7
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.8
—
1982.00
—
0
5
0
6
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
17.75
—
0
6
0
8
0.00
-0.00
0.0
9.4
—
—
—
0
0
5
49
1.02
-0.00
1.0
1.5
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: C3_BONE_CARTILAGE – Malignant neoplasm of bone and articular cartilage

GWS hits: 2

This endpoint is excluded from FinRegistry analyses (omitted endpoint).